Central venous access device practice across haematology and oncology centres in Australia and New Zealand: a cross-sectional survey

Hiu L A Yuen; Robert Weinkove; Amanda Ullman; Nicole Marsh; Claire M Rickard; Sanjeev Chunilal; Zoe McQuilten

doi:10.1111/imj.16031

Central venous access device practice across haematology and oncology centres in Australia and New Zealand: a cross-sectional survey

Intern Med J. 2023 Mar;53(3):426-430. doi: 10.1111/imj.16031. Epub 2023 Mar 15.

Authors

Hiu L A Yuen^{1

2}, Robert Weinkove^{3

4

5}, Amanda Ullman^{6

7

8}, Nicole Marsh^{6

9

10}, Claire M Rickard^{6

9

10

11}, Sanjeev Chunilal^{1

2}, Zoe McQuilten^{1

2}

Affiliations

¹ Monash Haematology, Monash Health, Melbourne, Victoria, Australia.
² Monash University, Melbourne, Victoria, Australia.
³ Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand.
⁴ Te Rerenga Ora Blood & Cancer Centre, Wellington Hospital, Wellington, New Zealand.
⁵ Department of Pathology and Molecular Medicine, University of Otago Wellington, Wellington, New Zealand.
⁶ School of Nursing, Midwifery and Social Work, The University of Queensland Centre for Clinical Research, Brisbane, Queensland, Australia.
⁷ Queensland Children's Hospital, Brisbane, Queensland, Australia.
⁸ Menzies Health Institute Queensland and School of Nursing and Midwifery, Griffith University, Brisbane, Queensland, Australia.
⁹ Alliance for Vascular Access Teaching and Research (AVATAR) Group, Schools of Nursing and Midwifery, and Pharmacy and Medical Sciences, Griffith University, Brisbane, Queensland, Australia.
¹⁰ Nursing and Midwifery Research Centre, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
¹¹ Herston Infectious Diseases Institute, Metro North Health, Brisbane, Queensland, Australia.

PMID: 36920141
DOI: 10.1111/imj.16031

Abstract

Central venous access devices (CVADs) are commonly used in malignancies. We conducted an online, anonymous cross-sectional survey of practice regarding CVAD management in haematology centres among clinicians in Australia and New Zealand. We identified variation in clinical practice regarding CVAD selection, insertion, management and removal. These findings highlight research gaps in CVAD care.

Keywords: cannula; neoplasms; venous access devices.

MeSH terms

Australia
Catheterization, Central Venous*
Central Venous Catheters*
Cross-Sectional Studies
Hematology*
Humans
New Zealand

Grants and funding

Not applicable/Australian Government Research Training Program (RTP) Scholarship